Edition:
United States

Aurinia Pharmaceuticals Inc (AUPH.OQ)

AUPH.OQ on NASDAQ Stock Exchange Global Market

4.95USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$4.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
171,670
52-wk High
$10.54
52-wk Low
$2.03

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 4 0.05 0.10 0.03 0.03
Quarter Ending Mar-18 2 0.03 0.03 0.03 --
Year Ending Dec-17 5 0.41 0.42 0.40 0.18
Year Ending Dec-18 5 13.19 65.18 0.11 0.18
Earnings (per share)
Quarter Ending Dec-17 4 -0.15 -0.08 -0.19 -0.15
Quarter Ending Mar-18 2 -0.19 -0.18 -0.20 --
Year Ending Dec-17 6 -1.02 -0.86 -1.19 -0.33
Year Ending Dec-18 6 -0.55 0.28 -0.87 -0.57
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 188.50 35.37
P/E High - Last 5 Yrs. -- 275.44 45.18
P/E Low - Last 5 Yrs. -- 92.47 24.20
Beta -- 0.82 0.91
Price to Sales (TTM) -- 113.76 5.84
Price to Book (MRQ) -- 21.88 5.65
Price to Tangible Book (MRQ) -- 25.71 7.25
Price to Cash Flow (TTM) -- 102.10 24.30
% Owned Institutions -- 5.62 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 97.35 46.04

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -3.12 6.82
Sales (TTM) vs TTM 1 Yr. Ago -- 30.10 5.63
Sales - 5 Yr. Growth Rate -- 33.18 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago -- -148.25 7.98
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 43.65 10.92
Capital Spending - 5 Yr. Growth Rate -- 40.96 15.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.55
Current Ratio (MRQ) -- 5.70 3.56
LT Debt to Equity (MRQ) -- 14.49 13.37
Total Debt to Equity (MRQ) -- 16.95 19.40
Interest Coverage (TTM) -- -138.10 44.77

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.91 54.89
Gross Margin - 5 Yr. Avg. -- 55.68 52.44
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -215.89 15.52
Operating Margin (TTM) -- -626.98 6.76
Operating Margin - 5 Yr. Avg. -- -232.77 11.02
Pre-Tax Margin (TTM) -- -597.81 7.58
Pre-Tax Margin - 5 Yr. Avg. -- -233.06 11.42
Net Profit Margin (TTM) -- -595.34 3.81
Net Profit Margin - 5 Yr. Avg. -- -236.34 7.71
Effective Tax Rate (TTM) -- 15.36 24.25
Effective Tax Rate - 5 Yr. Avg. -- 18.92 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 21,716,698 852,152,758
Net Income/Employee (TTM) -- -1,723,651 99,529,045
Receivable Turnover (TTM) -- 26.31 6.14
Inventory Turnover (TTM) -- 2.63 3.55
Asset Turnover (TTM) -- 0.42 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -9.30 11.32
Return on Assets - 5 Yr. Avg. -- 0.22 12.29
Return on Investment (TTM) -- -11.67 14.45
Return on Investment - 5 Yr. Avg. -- 3.35 16.09
Return on Equity (TTM) -- -36.21 16.05
Return on Equity - 5 Yr. Avg. -- 5.77 17.30

Performance for Aurinia Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.